HOME >> BIOLOGY >> NEWS
ASM Biodefense Research Meeting

The American Society for Microbiology (ASM) will host its 2006 Biodefense Research Meeting from February 15-18, 2006 at the Hyatt Regency Washington, DC.

There is a continuing need for research that helps protect the public against not only the traditional agents of bioterrorism, like anthrax, but also against emerging infectious diseases that hold the potential for serious human and economic harm, such as H5N1 influenza.

The purpose of this meeting is to identify existing state-of-the-art research in the biomedical sciences that can be adapted to address biodefense needs. This includes vaccine development and testing, new and faster diagnostics for biothreat agents, and new treatments for potential biowarfare agents. The meeting will also focus on better understanding of potential modes of disease transmission and factor affecting both bacterial and viral virulence.

The first day of the conference will be devoted two concurrent Focus Sessions focusing respectively on microbial forensics and the risk of biothreat agents in our drinking water. These will be followed by the Opening Session which includes a keynote address by Anthony Fauci, Director of the National Institute of Allergy and Infectious Disease.

Additional presentation topics include:

  • New Vaccine Strategies for Biothreat Agents
  • Influenza: Planning for the Next Pandemic
  • Insight into Evolution and Animal Origins of SARS


'"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
24-Jan-2006


Page: 1

Related biology news :

1. ASM Biodefense and Emerging Diseases Research Meeting
2. Gilbert Foundation and American Fed for Aging Research award grants on Alzheimers disease
3. Research shows skeleton to be endocrine organ
4. Research aims to identify markers for menopausal women at risk for deadly blood clot
5. Research team enlightens the reasons for severe blindness
6. Research teams uncover risk genes for multiple sclerosis
7. Research shows NPD1 protects a key component of vision
8. Researchers find pathway that controls cell size and division
9. Researchers watch antibiotics, bacteria meet at atomic level
10. Researchers discover gene responsible for Restless Legs Syndrome
11. Research study describes the role part of the brain plays in memory

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2017)... , Jan. 24, 2017  It sounds ... baby,s sock that monitors vital signs and alerts ... an infant,s oxygen saturation level drops. But pediatric ... alarm to parents, with no evidence of medical ... devices are marketed aggressively to parents of healthy ...
(Date:1/19/2017)... CLARA, Calif. , Jan. 19, 2017 /PRNewswire/ ... company enhancing user experience and security for consumer ... of next-generation payment processing systems and cybersecurity solutions, ... more banks, enterprises and financial institutions worldwide to ... part of the end-to-end secure user authentication platforms ...
(Date:1/12/2017)... , Jan. 12, 2017  Trovagene, Inc. (NASDAQ: ... DNA (ctDNA) technologies, today announced that it has signed ... and the Middle East ...  This milestone marks the first wave of international distribution ... urine and blood samples. The initial partners ...
Breaking Biology News(10 mins):
(Date:2/17/2017)... Feb. 17, 2017  If only one in ... a mutation-conferring resistance to chemotherapy, thousands of cancer ... has focused on finding these mutations in ever-smaller ... circulating tumor DNA in blood — to guide ... Unfortunately, however, detecting these genetic anomalies ...
(Date:2/16/2017)... MI (PRWEB) , ... February 16, 2017 , ... Avomeen ... p.m. The event will be held at Avomeen Analytical Services (4840 Venture Dr., ... a MichBio member organization. They provide an opportunity to interact with peers, make new ...
(Date:2/16/2017)... , Feb. 16, 2017  ArmaGen, Inc., ... groundbreaking therapies to treat severe neurological disorders, today ... treated with AGT-181, the company,s investigational therapy for ... known as mucopolysaccharidosis type I, or MPS I). ... proof-of-concept (POC) study, presented today at the 13 ...
(Date:2/16/2017)... 2017 Patient Care services ... telemedicine application, new and leading edge therapies and ... boom worldwide. The healthcare sector as whole continues ... and new therapies for companies such as Reliq ... Biosciences, Inc. (NASDAQ: CLRB ), Cytori ...
Breaking Biology Technology:
Cached News: